ABAX Shares Outstanding History
Below is a table of the ABAX shares outstanding history going back to 2/5/2010:

Date ABAX Shares Outstanding
2/5/201022.08M
6/9/201022.29M
8/5/201022.32M
11/5/201022.35M
2/7/201122.52M
6/9/201122.75M
8/4/201122.82M
11/4/201121.68M
2/6/201221.69M
6/11/201221.89M
8/6/201221.93M
11/6/201221.95M
2/6/201322.10M
6/11/201322.28M
8/6/201322.32M
11/8/201322.27M
2/5/201422.25M
5/27/201422.46M
5/30/201422.46M
8/6/201422.52M
11/6/201422.54M
2/5/201522.54M
5/27/201522.67M
5/29/201522.67M
8/6/201522.72M
11/6/201522.72M
2/8/201622.64M
5/26/201622.50M
8/8/201622.53M
11/8/201622.54M
2/7/201722.54M
5/26/201722.65M
8/7/201722.69M
11/7/201722.70M
2/7/201822.70M
5/25/201822.87M

Also see: ABAX Market Cap History
and ABAX YTD Return
ABAX Historical Shares Outstanding:
+0.42% CAGR
ABAX Historical Shares Outstanding: +0.42% CAGR

Mouse over chart for data details
2/5/2010 ...5/25/2018
Abaxis is engaged in developing, manufacturing and marketing portable blood analysis systems for use in the human or veterinary patient-care to provide clinicians with blood constituent measurements. Co. has two business segments: medical market, with products manufactured and sold in this segment primarily consist of Piccolo chemistry analyzers and medical reagent discs; and veterinary market, with product offerings that include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests. We show 36 historical shares outstanding datapoints in our coverage of ABAX's shares outstanding history.

Understanding the changing numbers of ABAX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ABAX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ABAX by allowing them to research ABAX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ABAX:
ABAX SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Abaxis (ABAX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ABBV Shares Outstanding History
ABC Shares Outstanding History
ABEO Shares Outstanding History
ABIO Shares Outstanding History
ABMD Shares Outstanding History
ABT Shares Outstanding History
ACAD Shares Outstanding History
ACER Shares Outstanding History
ACET Shares Outstanding History
ACHC Shares Outstanding History
More Healthcare companies »

 

ABAX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2018, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.